Af­ter a pa­tient death in NKT tri­al, Athenex hires chief re­struc­tur­ing of­fi­cer

Athenex is bring­ing on a chief re­struc­tur­ing of­fi­cer as the Buf­fa­lo, NY-based biotech con­sid­ers “strate­gic al­ter­na­tives” fol­low­ing a clin­i­cal hold for its nat­ur­al killer cell …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER